MoneyWorks4Me

Alkem Laboratories informs about quarterly statement on investor complaints

11 Jan 2017 Evaluate

Alkem Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.10
Dr. Reddys Labs. 1313.50
Cipla 1326.65
Lupin 1948.00
Zydus Lifesciences 1168.35
View more..